510(k) Report

PMA · Approved

Recalled · Class II · 2026

Aptima HPV Assay

P100042PMAApproved Oct 28, 2011357-day reviewClass IIIRecalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Gen-Probe Incorporated · OYB Kit, Rna Detection, Human Papillomavirus

Approved on Oct 28, 2011 through premarket approval, which rests on the device’s own clinical evidence after a 357-day review. It has been recalled once.

Decided
Oct 28, 2011
Review
357 days
Class
Class III
Product code
OYB
Recalls
1

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P100042 has 38 supplements since 2013: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2013: 12014: 22015: 42016: 32017: 22018: 62019: 72020: 52022: 22023: 22024: 22025: 12026: 1
2013high 7 (2019) · low 0 (2021)2026
View FIG. 1 as a table
YearSupplements approved
20131
20142
20154
20163
20172
20186
20197
20205
20222
20232
20242
20251
20261
FIG. 1 — Supplements to P100042, 2013–2026Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OYB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Feb 18, 2026Class IIZ-1586-2026Under Investigation by firmDue to product exhibiting potential to generate either invalid or false negative results.

No ancestor or descendant has a Class I recall.

How does its category compare?

All OYB devices

OYB Kit, Rna Detection, Human Papillomavirus: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · OYB

2in 2025

2011: 12012: 12013: 22014: 32015: 72016: 62017: 42018: 122019: 142020: 92022: 32023: 32024: 42025: 22026 (partial year): 2
2007high 14 (2019) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OYB

Too few OYB 510(k)s in any year since 2007 to give a median.

Recalls per year · OYB

No recall names OYB since 2007.

Adverse event reports per year · OYB

21in 2025

2016: 12017: 12018: 22021: 32022: 12024: 32025: 21
2007high 21 (2025) · low 0 (2007)2025

MAUDE reports naming product code OYB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20111—00
20121—00
20132—00
20143—00
20157—00
20166—01
20174—01
201812—02
201914—00
20209—00
20210—03
20223—01
20233—00
20244—03
20252—021
20262—0—
Cite this page

510(k) Report. “P100042: Aptima HPV Assay.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/P100042

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026